相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters
Lunzhi Yuan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages
Zhenfeng Wang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2022)
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses
Anbalagan Anantharaj et al.
JOURNAL OF CLINICAL VIROLOGY (2022)
The cholesterol pathway: impact on immunity and cancer
Ryan J. King et al.
TRENDS IN IMMUNOLOGY (2022)
Persisting lung pathogenesis and minimum residual virus in hamster after acute COVID-19
Lunzhi Yuan et al.
PROTEIN & CELL (2022)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Combining Antivirals and Immunomodulators to Fight COVID-19
Vincent Feuillet et al.
TRENDS IN IMMUNOLOGY (2021)
Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors
Yali Zhang et al.
SMALL METHODS (2021)
Tailoring Materials for Modulation of Macrophage Fate
Jinhua Li et al.
ADVANCED MATERIALS (2021)
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition
Xiangzhao Ai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Nanotechnology for virus treatment
Jiarong Zhou et al.
NANO TODAY (2021)
SARS-CoV-2 spike D614G change enhances replication and transmission
Bin Zhou et al.
NATURE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
The prevalence of antibodies to SARS-CoV-2 among blood donors in China
Le Chang et al.
NATURE COMMUNICATIONS (2021)
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Shea A. Lowery et al.
CELL HOST & MICROBE (2021)
Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates
Stephanie Reynard et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19
Zhenhua Li et al.
NATURE NANOTECHNOLOGY (2021)
Inhalable nanocatchers for SARS-CoV-2 inhibition
Han Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response
Yu-Zhi Fu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Targeting 7-Dehydrocholesterol Reductase Integrates Cholesterol Metabolism and IRF3 Activation to Eliminate Infection
Jun Xiao et al.
IMMUNITY (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Cell membrane-derived biomimetic nanodecoys for viruses
Liu Xuan et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
Lang Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
Jin-Yan Li et al.
VIRUS RESEARCH (2020)
Evasion of Type I Interferon by SARS-CoV-2
Hongjie Xia et al.
CELL REPORTS (2020)
On the genetics and immunopathogenesis of COVID-19
Chaim Oscar Jacob
CLINICAL IMMUNOLOGY (2020)
SARS-CoV-2 evades immune detection in alveolar macrophages
Louise Dalskov et al.
EMBO REPORTS (2020)
Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients
Amir Shlomai et al.
CRITICAL CARE (2020)
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists
Chun-Kit Yuen et al.
EMERGING MICROBES & INFECTIONS (2020)
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Rudragouda Channappanavar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly Development
Lang Rao et al.
NANO LETTERS (2019)
T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity
Xiaoli Wei et al.
ADVANCED MATERIALS (2018)
Bioinspired Artificial Nanodecoys for Hepatitis B Virus
Xuan Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver
Mathilde Dusseaux et al.
GASTROENTEROLOGY (2017)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets
Yang Yang et al.
SCIENTIFIC REPORTS (2015)
Inhibiting host-pathogen interactions using membrane-based nanostructures
Daniel A. Bricarello et al.
TRENDS IN BIOTECHNOLOGY (2012)
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Allison L. Totura et al.
CURRENT OPINION IN VIROLOGY (2012)
Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman et al.
NATURE REVIEWS MICROBIOLOGY (2009)